Albendazole-Induced Anagen Effluvium

    December 2019 in “ JAAD Case Reports ”
    Mondana Ghias, Bijal Amin, Allison Kutner
    Studysummary This paper discusses anagen effluvium, a reversible non-scarring hair loss often triggered by certain chemotherapy drugs, but presents no new clinical results.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on jaadcasereports.org →
    Discuss this study in the Community →

    Research cited in this study 7

    1. Pigmented Casts in Alopecia: A 2014 Study The American Journal of Dermatopathology · 2013
    2. Telogen Effluvium After Oral Albendazole Clinical and Experimental Dermatology · 2012
    3. Follicular Swiss Cheese Pattern: Another Histopathologic Clue to Alopecia Areata Journal of Cutaneous Pathology · 2010
    4. Telogen Effluvium: Causes, Diagnosis, and Treatment Clinical and Experimental Dermatology · 2002
    5. Medical Treatment of Liver Hydatidosis World Journal of Surgery · 2001
    6. Eosinophils in Fibrous Tracts and Near Hair Bulbs: A Helpful Diagnostic Feature of Alopecia Areata Journal of The American Academy of Dermatology · 1997
    7. Albendazole Treatment of Echinococcosis in Humans: Effects on Microsomal Metabolism and Drug Tolerance Clinical pharmacology and therapeutics/Clinical pharmacology & therapeutics · 1990